Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 9
Submit an article Journal homepage
1,003
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation

Natsuyo Ugumoria Department of Obstetrics and Gynecology , Tsubaki Women’s Clinic, Matsuyama, JapanView further author information
,
Yutaka Uedab Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanCorrespondence[email protected]
View further author information
,
Asami Yagib Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Hazuki Abeb Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Mayu Shiomib Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Satoshi Nakagawab Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Kosuke Hiramatsub Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Ai Miyoshib Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Eiji Kobayashib Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Toshihiro Kimurab Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
,
Tadashi Kimurab Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, JapanView further author information
&
Motowo Nabetaa Department of Obstetrics and Gynecology , Tsubaki Women’s Clinic, Matsuyama, JapanView further author information
 show all
Pages 3096-3101 | Received 07 Feb 2021, Accepted 23 Mar 2021, Published online: 20 Apr 2021

References

  • Yagi A, Ueda Y, Kakuda M, Tanaka Y, Ikeda S, Matsuzaki S, Kobayashi E, Morishima T, Miyashiro I, Fukui K, et al. Epidemiologic and clinical analysis of cervical cancer using data from the population-based Osaka cancer registry. Cancer Res. 2019;79(6):1252–59. doi:10.1158/0008-5472.CAN-18-3109.
  • Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, Miyagi E, Sekine M, Enomoto T, Kudoh K. HPV vaccination in Japan: what is happening in Japan? Expert Rev Vaccines. 2019;18(4):323–25. doi:10.1080/14760584.2019.1584040.
  • Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385(9987):2571. doi:10.1016/S0140-6736(15)61152-7.
  • Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan’s failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol. 2015;212(3):405–06. doi:10.1016/j.ajog.2014.11.037.
  • Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T. Japanese crisis of HPV vaccination. Int J Pathol Clin Res. 2016;2(2):039. doi:10.23937/2469-5807/1510039.
  • Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Science. 2020;111(6):2156–62. doi:10.1111/cas.14406.
  • Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–48. doi:10.1056/NEJMoa1917338.
  • Ueda Y, Yagi A, Nakayama T, Hirai K, Ikeda S, Sekine M, Miyagi E, Enomoto T. Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year. Sci Rep. 2018;8(1):5612. doi:10.1038/s41598-018-23947-6.
  • Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane Rev Randomized Trials Expert Rev Vaccines. 2018;17:1085–91.
  • Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res.2018;(5):96–103.
  • Ueda Y, Yagi A, Abe H, Nakagawa S, Minekawa R, Kuroki H, Miwa A, Kimura T. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation. Sci Rep. 2020;10(1):16091. doi:10.1038/s41598-020-73120-1.
  • Yagi A, Ueda Y, Masuda T, Ikeda S, Miyatake T, Nakagawa S, Hirai K, Nakayama T, Miyagi E, Enomoto T, et al. Japanese mothers’ intention to HPV vaccinate their daughters: how has it changed over time because of the prolonged suspension of the governmental recommendation? Vaccines (Basel). 2020;8(3):502. doi:10.3390/vaccines8030502.
  • Shiomi M, Ueda Y, Abe H, Yagi A, Sakiyama K, Kimura T, Tanaka Y, Ohmichi M, Ichimura T, Sumi T, et al. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare’s revised HPV vaccine leaflet. Hum Vaccin Immunother. 2020;16(10):2555–58. doi:10.1080/21645515.2020.1723362.
  • Yagi A, Ueda Y, Nakagawa S, Ikeda S, Tanaka Y, Sekine M, Miyagi E, Enomoto T, Kimura T. Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine. Sci Rep. 2020;10(1):15945. doi:10.1038/s41598-020-73106-z.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.